Aspen Aerogels, Inc. ASPN
5.22
(0.08)
(1.51%)
as of 25 Sep
- Market cap
- $440.7M
- P/E
- 0.0×
Follow ASPN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
2.60 | 1.23 | 0.86 | 1.63 | |
P/FCF ratio |
15.29 | 7.96 | 0.00 | 213.59 | |
P/Operating CF |
(32.44) | 8.29 | 14.44 | 38.14 | |
P/B ratio |
2.73 | 1.33 | 0.99 | 1.88 | |
Price to Tangible BV |
2.73 | 1.33 | 0.99 | 1.88 | |
EV/Sales |
2.30 | 0.87 | 0.68 | 1.51 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
9.48 | 3.26 | 5.61 | 10.14 | |
EV/FCF |
13.55 | 5.62 | (40.26) | 197.92 | |
Quick Ratio |
1.96 | 2.41 | 3.13 | 3.13 | |
Current Ratio |
2.52 | 2.89 | 3.90 | 3.94 | |
Net Debt/EBITDA |
2.62 | 6.05 | 1.18 | (14.05) | |
Debt/Assets |
23.82% | 22.54% | 27.02% | 22.45% | |
Debt/Equity |
0.49 | 0.43 | 0.47 | 0.36 | |
Asset Turnover |
0.44 | 0.48 | 0.42 | 0.55 | |
Operating CF/Net income |
0.70 | (1.44) | (0.22) | (2.37) | |
Capex/Depreciation |
(0.30) | (0.19) | (0.08) | (1.43) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
6.41% | 7.19% | 6.76% | 3.42% | |
Selling, General and Administrative Expense of Revenue |
40.01% | 57.96% | 52.46% | 27.51% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
3.75% | 4.93% | 4.06% | 2.99% | |
Graham Net Nets |
0.09 | 0.20 | 0.30 | 0.16 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(24.13%) | (39.77%) | (167.49%) | (53.45%) | |
Free Cash Flow Yield |
6.54% | 12.57% | (1.96%) | 0.47% | |
Revenue per Share |
0.60 | 0.46 | 0.50 | 0.89 | |
Operating CF per Share |
(0.20) | 0.41 | 0.20 | 0.18 | |
Capex per Share |
(0.02) | (0.02) | (0.03) | (0.11) | |
Free Cash Flow per Share |
(0.22) | 0.40 | 0.17 | 0.07 | |
Cash per Share |
1.85 | 2.12 | 1.93 | 1.85 | |
Shareholders Equity per Share |
2.32 | 2.58 | 2.86 | 3.71 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.32 | 2.58 | 2.86 | 3.71 | |
Free Cash Flow |
(18.00) | 32.78 | 13.67 | 5.93 | |
Working Capital |
149.85 | 166.17 | 180.03 | 208.18 | |
Capital Expenditures |
(1.80) | (1.37) | (2.46) | (9.10) | |
Net Current Asset Value |
48.02 | 56.99 | 70.89 | 93.26 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.04 | 0.06 | 0.12 | |
Net Profit Margin |
(46.67%) | (62.54%) | (176.38%) | (8.67%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
58.22 | 56.90 | 72.19 | 92.17 | |
Average Payables |
23.98 | 26.77 | 28.80 | 30.69 | |
Average Inventory |
40.03 | 43.90 | 42.90 | 45.23 | |
Average Assets |
459.03 | 482.73 | 650.91 | 636.99 | |
Average Common Equity |
250.62 | 264.17 | 425.11 | 406.69 |
Columns are period end dates